Reaction

B-Cell Lymphoma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,372 reports · 104 co-occurring drugs

As of the last recalculation, B-Cell Lymphoma appears in 3,372 FAERS reports alongside 104 co-occurring drug terms. The strongest observed disproportionality signal is AXICABTAGENE CILOLEUCEL (PRR 27.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Axicabtagene Ciloleucel	44	27.9	28.0
Bendamustine Hcl	67	27.2	27.3
Bendamustine Hydrochloride	34	17.7	17.7
Mycophenilic Acid	54	16.3	16.4
Rituximab	428	14.2	14.2
Doxorubicin	192	14.0	14.1
Mercaptopurine	38	13.7	13.7
Alemtuzumab	42	13.6	13.6
Basiliximab	25	13.2	13.2
Obinutuzumab	34	12.9	12.9
Vincristine Sulfate	58	12.4	12.4
Cyclophosphamide Injection, Solution	317	12.1	12.1
Cyclophosphamide	317	12.1	12.1
Cyclophosphamide For Injection	317	12.1	12.1
Doxorubicin Hydrochloride	61	11.7	11.7
Ifosfamide	40	11.6	11.6
Mycophenolic Acid	59	11.6	11.6
Polatuzumab Vedotin	18	11.4	11.5
Sirolimus	23	10.6	10.6
Azathioprine	141	10.3	10.3
Fludarabine Phosphate	60	9.6	9.6
Atovaquone	12	9.2	9.2
Adalimumab-Fkjp	67	9.1	9.1
Adalimumab-Aaty	67	8.9	8.9
Infliximab	288	8.8	8.8
Anti-Thymocyte Globulin (Rabbit)	11	8.4	8.5
Romiplostim	20	8.2	8.3
Mesna Injection	11	8.2	8.3
Prednisolone	224	8.1	8.1
Prednisolone Oral	224	8.1	8.1
Prednisolone Oral Solution	224	8.1	8.1
Mesna	11	8.1	8.1
Etoposide	93	8.0	8.0
Adalimumab-Adaz	67	8.0	8.0
Minocycline	15	8.0	8.0
Methotrexate Sodium	520	7.6	7.6
Mycophenolate Mofetil	160	7.6	7.6
Mycophenolate Mofetil Hydrochloride	160	7.6	7.6
Methotrexate	446	7.4	7.4
Cladribine	11	7.1	7.1
Ganciclovir Sodium	12	7.0	7.0
Tacrolimus Ointment 0.1%	134	6.9	6.9
Tacrolimus Extended-Release Capsules	134	6.9	6.9
Ganciclovir	11	6.7	6.7
Cytarabine	63	6.6	6.6
Tacrolimus	159	6.5	6.5
Bleomycin Sulfate	10	6.0	6.0
Filgrastim	34	5.6	5.6
Cyclosporine	98	5.6	5.6
Ursosiol	16	5.1	5.1
Valganciclovir Hydrochloride Powder,	10	5.1	5.1
Dexamethasone Sodium Phosphate	8	4.9	4.9
Entecavir	9	4.8	4.8
Valganciclovir	14	4.6	4.6
Valganciclovir Hydrochloride	14	4.6	4.6
Ursodiol	16	4.6	4.6
Olaparib	15	4.4	4.4
Erythropoietin	14	4.2	4.2
Terbinafine Hydrochloride	6	4.2	4.2
Raltegravir	11	4.1	4.1
Sofosbuvir	13	4.1	4.1
Gemcitabine	25	3.9	3.9
Quinapril Hydrochloride	5	3.9	3.9
Cefepime	9	3.9	3.9
Valacyclovir	26	3.9	3.9
Ledipasvir And Sofosbuvir	12	3.9	3.9
Cisplatin	47	3.8	3.8
Venetoclax	37	3.7	3.7
Tenofovir Disoproxil Fumarate Tablets	5	3.6	3.6
Golimumab	49	3.6	3.6
Granisetron Hydrochloride	6	3.6	3.6
Ibrutinib	46	3.5	3.6
Imatinib	10	3.5	3.5
Clozapine	70	3.5	3.5
Cefepime Hydrochloride	9	3.5	3.5
Zonisamide	8	3.3	3.3
Thiotepa	5	3.2	3.2
Lenalidomide	209	3.2	3.2
Gemcitabine Hydrochloride	27	3.2	3.2
Fingolimod Hcl	43	3.1	3.1
Dabrafenib	10	2.9	2.9
Ixekizumab	17	2.8	2.8
Tofacitinib Citrate	6	2.8	2.8
Trametinib	10	2.6	2.6
Temozolomide	8	2.3	2.3
Ozanimod Hydrochloride	3	2.2	2.2
Ustekinumab	35	2.1	2.1
Certolizumab Pegol	40	2.1	2.1
Ribavirin	22	2.1	2.1
Etanercept	199	2.1	2.1
Vismodegib	3	2.1	2.1
Gefitinib	3	2.1	2.1
Natalizumab	58	2.0	2.0
Guselkumab	11	1.9	1.9
Eltrombopag Olamine	7	1.9	1.9
Ofatumumab	10	1.9	1.9
Pirfenidone	12	1.8	1.8
Blinatumomab	3	1.8	1.8
Ranitidine Hydrochloride	15	1.7	1.7
Tenofovir Disoproxil Fumarate	9	1.7	1.7
Glatiramer Acetate	15	1.6	1.6
Pegfilgrastim	22	1.4	1.4
Dulaglutide	15	1.0	1.0
Apremilast	24	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.